FDA and sponsors have boiled down consumer safety information for long-acting/extended-release opioids into one-page, drug-specific Medication Guides that are to be distributed to patients beginning Aug. 8.
The MedGuides, which highlight the risks patients should consider before taking the narcotic pain killers and actions to ensure safe use, are part of the Risk Evaluation and Mitigation Strategies...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?